Medical Device Design Development Services Market

ID: MRFR/MED/20410-HCR
128 Pages
Nidhi Mandole
Last Updated: April 06, 2026
Medical Device Design and Development Services Market Research Report Information By Service (Designing & Engineering, Machining, Molding and Packaging), By Medical Devices (Cardiovascular Devices (Ventricular Assist Devices, Total Artificial Hearts, Pacemakers, Implantable Cardioverter Defibrillators (ICDs), Cardiac Loop Recorders, Holter Monitors, Event Monitors, ECMO Systems, Consumables), POC Diagnostic Equipment (Blood Glucose Monitor, Blood Analyzer, Blood Pressure Monitor, Pregnancy Test Kit, Infectious Diseases Testing), Hb1Ac Testing (Coagulation Testing Kit, Cardiac Markers Test, Thyroid Stimulating Hormone Test, Others), Market Forecast Till 2035
Medical Device Design Development Services Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)13.6%
2024 Market Size$ 12.4 Billion
2025 Market Size$ 14.09 Billion
2035 Market Size$ 50.43 Billion
Key Players
Medtronic
Boston Scientific
Johnson & Johnson
Stryker
Abbott Laboratories
B. Braun Melsungen AG
Trends
  • Increased Focus on User-Centric Design
  • Integration of Advanced Technologies
  • Regulatory Adaptation and Compliance
Opportunities
  • Technological Advancements in Medical Devices
  • Rising Demand for Personalized Medical Devices
  • Expansion of Telehealth and Remote Monitoring Solutions
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Service (USD Billion)
      1. 4.1.1 Designing & Engineering
      2. 4.1.2 Machining
      3. 4.1.3 Molding
      4. 4.1.4 Packaging
    2. 4.2 Healthcare, BY Medical Devices (USD Billion)
      1. 4.2.1 Cardiovascular Devices
      2. 4.2.2 POC Diagnostic Equipment
      3. 4.2.3 Hb1Ac Testing
      4. 4.2.4 Drug Delivery Devices
      5. 4.2.5 Orthopedic Devices
      6. 4.2.6 Dental Devices
      7. 4.2.7 Surgical Devices
      8. 4.2.8 Imaging Devices
      9. 4.2.9 Sleep & Respiratory Devices
      10. 4.2.10 Ophthalmology Devices
      11. 4.2.11 Endoscopy
      12. 4.2.12 Diabetes Care
      13. 4.2.13 Cochlear Implants
      14. 4.2.14 Neurostimulators
      15. 4.2.15 Others
    3. 4.3 Healthcare, BY Therapeutic Area (USD Billion)
      1. 4.3.1 Cardiovascular
      2. 4.3.2 Diagnostic
      3. 4.3.3 Others
    4. 4.4 Healthcare, BY End-Use (USD Billion)
      1. 4.4.1 Medical Device Companies
      2. 4.4.2 Biotechnology Companies
    5. 4.5 Healthcare, BY Region (USD Billion)
      1. 4.5.1 North America
        1. 4.5.1.1 US
        2. 4.5.1.2 Canada
      2. 4.5.2 Europe
        1. 4.5.2.1 Germany
        2. 4.5.2.2 UK
        3. 4.5.2.3 France
        4. 4.5.2.4 Russia
        5. 4.5.2.5 Italy
        6. 4.5.2.6 Spain
        7. 4.5.2.7 Rest of Europe
      3. 4.5.3 APAC
        1. 4.5.3.1 China
        2. 4.5.3.2 India
        3. 4.5.3.3 Japan
        4. 4.5.3.4 South Korea
        5. 4.5.3.5 Malaysia
        6. 4.5.3.6 Thailand
        7. 4.5.3.7 Indonesia
        8. 4.5.3.8 Rest of APAC
      4. 4.5.4 South America
        1. 4.5.4.1 Brazil
        2. 4.5.4.2 Mexico
        3. 4.5.4.3 Argentina
        4. 4.5.4.4 Rest of South America
      5. 4.5.5 MEA
        1. 4.5.5.1 GCC Countries
        2. 4.5.5.2 South Africa
        3. 4.5.5.3 Rest of MEA
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Medtronic (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Boston Scientific (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Johnson & Johnson (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Stryker (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Abbott Laboratories (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 B. Braun Melsungen AG (DE)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Siemens Healthineers (DE)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 GE Healthcare (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Philips Healthcare (NL)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 NORTH AMERICA MARKET ANALYSIS
    3. 6.3 US MARKET ANALYSIS BY SERVICE
    4. 6.4 US MARKET ANALYSIS BY MEDICAL DEVICES
    5. 6.5 US MARKET ANALYSIS BY THERAPEUTIC AREA
    6. 6.6 US MARKET ANALYSIS BY END-USE
    7. 6.7 CANADA MARKET ANALYSIS BY SERVICE
    8. 6.8 CANADA MARKET ANALYSIS BY MEDICAL DEVICES
    9. 6.9 CANADA MARKET ANALYSIS BY THERAPEUTIC AREA
    10. 6.10 CANADA MARKET ANALYSIS BY END-USE
    11. 6.11 EUROPE MARKET ANALYSIS
    12. 6.12 GERMANY MARKET ANALYSIS BY SERVICE
    13. 6.13 GERMANY MARKET ANALYSIS BY MEDICAL DEVICES
    14. 6.14 GERMANY MARKET ANALYSIS BY THERAPEUTIC AREA
    15. 6.15 GERMANY MARKET ANALYSIS BY END-USE
    16. 6.16 UK MARKET ANALYSIS BY SERVICE
    17. 6.17 UK MARKET ANALYSIS BY MEDICAL DEVICES
    18. 6.18 UK MARKET ANALYSIS BY THERAPEUTIC AREA
    19. 6.19 UK MARKET ANALYSIS BY END-USE
    20. 6.20 FRANCE MARKET ANALYSIS BY SERVICE
    21. 6.21 FRANCE MARKET ANALYSIS BY MEDICAL DEVICES
    22. 6.22 FRANCE MARKET ANALYSIS BY THERAPEUTIC AREA
    23. 6.23 FRANCE MARKET ANALYSIS BY END-USE
    24. 6.24 RUSSIA MARKET ANALYSIS BY SERVICE
    25. 6.25 RUSSIA MARKET ANALYSIS BY MEDICAL DEVICES
    26. 6.26 RUSSIA MARKET ANALYSIS BY THERAPEUTIC AREA
    27. 6.27 RUSSIA MARKET ANALYSIS BY END-USE
    28. 6.28 ITALY MARKET ANALYSIS BY SERVICE
    29. 6.29 ITALY MARKET ANALYSIS BY MEDICAL DEVICES
    30. 6.30 ITALY MARKET ANALYSIS BY THERAPEUTIC AREA
    31. 6.31 ITALY MARKET ANALYSIS BY END-USE
    32. 6.32 SPAIN MARKET ANALYSIS BY SERVICE
    33. 6.33 SPAIN MARKET ANALYSIS BY MEDICAL DEVICES
    34. 6.34 SPAIN MARKET ANALYSIS BY THERAPEUTIC AREA
    35. 6.35 SPAIN MARKET ANALYSIS BY END-USE
    36. 6.36 REST OF EUROPE MARKET ANALYSIS BY SERVICE
    37. 6.37 REST OF EUROPE MARKET ANALYSIS BY MEDICAL DEVICES
    38. 6.38 REST OF EUROPE MARKET ANALYSIS BY THERAPEUTIC AREA
    39. 6.39 REST OF EUROPE MARKET ANALYSIS BY END-USE
    40. 6.40 APAC MARKET ANALYSIS
    41. 6.41 CHINA MARKET ANALYSIS BY SERVICE
    42. 6.42 CHINA MARKET ANALYSIS BY MEDICAL DEVICES
    43. 6.43 CHINA MARKET ANALYSIS BY THERAPEUTIC AREA
    44. 6.44 CHINA MARKET ANALYSIS BY END-USE
    45. 6.45 INDIA MARKET ANALYSIS BY SERVICE
    46. 6.46 INDIA MARKET ANALYSIS BY MEDICAL DEVICES
    47. 6.47 INDIA MARKET ANALYSIS BY THERAPEUTIC AREA
    48. 6.48 INDIA MARKET ANALYSIS BY END-USE
    49. 6.49 JAPAN MARKET ANALYSIS BY SERVICE
    50. 6.50 JAPAN MARKET ANALYSIS BY MEDICAL DEVICES
    51. 6.51 JAPAN MARKET ANALYSIS BY THERAPEUTIC AREA
    52. 6.52 JAPAN MARKET ANALYSIS BY END-USE
    53. 6.53 SOUTH KOREA MARKET ANALYSIS BY SERVICE
    54. 6.54 SOUTH KOREA MARKET ANALYSIS BY MEDICAL DEVICES
    55. 6.55 SOUTH KOREA MARKET ANALYSIS BY THERAPEUTIC AREA
    56. 6.56 SOUTH KOREA MARKET ANALYSIS BY END-USE
    57. 6.57 MALAYSIA MARKET ANALYSIS BY SERVICE
    58. 6.58 MALAYSIA MARKET ANALYSIS BY MEDICAL DEVICES
    59. 6.59 MALAYSIA MARKET ANALYSIS BY THERAPEUTIC AREA
    60. 6.60 MALAYSIA MARKET ANALYSIS BY END-USE
    61. 6.61 THAILAND MARKET ANALYSIS BY SERVICE
    62. 6.62 THAILAND MARKET ANALYSIS BY MEDICAL DEVICES
    63. 6.63 THAILAND MARKET ANALYSIS BY THERAPEUTIC AREA
    64. 6.64 THAILAND MARKET ANALYSIS BY END-USE
    65. 6.65 INDONESIA MARKET ANALYSIS BY SERVICE
    66. 6.66 INDONESIA MARKET ANALYSIS BY MEDICAL DEVICES
    67. 6.67 INDONESIA MARKET ANALYSIS BY THERAPEUTIC AREA
    68. 6.68 INDONESIA MARKET ANALYSIS BY END-USE
    69. 6.69 REST OF APAC MARKET ANALYSIS BY SERVICE
    70. 6.70 REST OF APAC MARKET ANALYSIS BY MEDICAL DEVICES
    71. 6.71 REST OF APAC MARKET ANALYSIS BY THERAPEUTIC AREA
    72. 6.72 REST OF APAC MARKET ANALYSIS BY END-USE
    73. 6.73 SOUTH AMERICA MARKET ANALYSIS
    74. 6.74 BRAZIL MARKET ANALYSIS BY SERVICE
    75. 6.75 BRAZIL MARKET ANALYSIS BY MEDICAL DEVICES
    76. 6.76 BRAZIL MARKET ANALYSIS BY THERAPEUTIC AREA
    77. 6.77 BRAZIL MARKET ANALYSIS BY END-USE
    78. 6.78 MEXICO MARKET ANALYSIS BY SERVICE
    79. 6.79 MEXICO MARKET ANALYSIS BY MEDICAL DEVICES
    80. 6.80 MEXICO MARKET ANALYSIS BY THERAPEUTIC AREA
    81. 6.81 MEXICO MARKET ANALYSIS BY END-USE
    82. 6.82 ARGENTINA MARKET ANALYSIS BY SERVICE
    83. 6.83 ARGENTINA MARKET ANALYSIS BY MEDICAL DEVICES
    84. 6.84 ARGENTINA MARKET ANALYSIS BY THERAPEUTIC AREA
    85. 6.85 ARGENTINA MARKET ANALYSIS BY END-USE
    86. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY SERVICE
    87. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY MEDICAL DEVICES
    88. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY THERAPEUTIC AREA
    89. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY END-USE
    90. 6.90 MEA MARKET ANALYSIS
    91. 6.91 GCC COUNTRIES MARKET ANALYSIS BY SERVICE
    92. 6.92 GCC COUNTRIES MARKET ANALYSIS BY MEDICAL DEVICES
    93. 6.93 GCC COUNTRIES MARKET ANALYSIS BY THERAPEUTIC AREA
    94. 6.94 GCC COUNTRIES MARKET ANALYSIS BY END-USE
    95. 6.95 SOUTH AFRICA MARKET ANALYSIS BY SERVICE
    96. 6.96 SOUTH AFRICA MARKET ANALYSIS BY MEDICAL DEVICES
    97. 6.97 SOUTH AFRICA MARKET ANALYSIS BY THERAPEUTIC AREA
    98. 6.98 SOUTH AFRICA MARKET ANALYSIS BY END-USE
    99. 6.99 REST OF MEA MARKET ANALYSIS BY SERVICE
    100. 6.100 REST OF MEA MARKET ANALYSIS BY MEDICAL DEVICES
    101. 6.101 REST OF MEA MARKET ANALYSIS BY THERAPEUTIC AREA
    102. 6.102 REST OF MEA MARKET ANALYSIS BY END-USE
    103. 6.103 KEY BUYING CRITERIA OF HEALTHCARE
    104. 6.104 RESEARCH PROCESS OF MRFR
    105. 6.105 DRO ANALYSIS OF HEALTHCARE
    106. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    107. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    108. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
    109. 6.109 HEALTHCARE, BY SERVICE, 2024 (% SHARE)
    110. 6.110 HEALTHCARE, BY SERVICE, 2024 TO 2035 (USD Billion)
    111. 6.111 HEALTHCARE, BY MEDICAL DEVICES, 2024 (% SHARE)
    112. 6.112 HEALTHCARE, BY MEDICAL DEVICES, 2024 TO 2035 (USD Billion)
    113. 6.113 HEALTHCARE, BY THERAPEUTIC AREA, 2024 (% SHARE)
    114. 6.114 HEALTHCARE, BY THERAPEUTIC AREA, 2024 TO 2035 (USD Billion)
    115. 6.115 HEALTHCARE, BY END-USE, 2024 (% SHARE)
    116. 6.116 HEALTHCARE, BY END-USE, 2024 TO 2035 (USD Billion)
    117. 6.117 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.2.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
      3. 7.2.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
      4. 7.2.4 BY END-USE, 2025-2035 (USD Billion)
    2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.3.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.3.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
      3. 7.3.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
      4. 7.3.4 BY END-USE, 2025-2035 (USD Billion)
    3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
      1. 7.4.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.4.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
      3. 7.4.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
      4. 7.4.4 BY END-USE, 2025-2035 (USD Billion)
    4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.5.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.5.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
      3. 7.5.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
      4. 7.5.4 BY END-USE, 2025-2035 (USD Billion)
    5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
      1. 7.6.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.6.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
      3. 7.6.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
      4. 7.6.4 BY END-USE, 2025-2035 (USD Billion)
    6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
      1. 7.7.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.7.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
      3. 7.7.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
      4. 7.7.4 BY END-USE, 2025-2035 (USD Billion)
    7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
      1. 7.8.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.8.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
      3. 7.8.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
      4. 7.8.4 BY END-USE, 2025-2035 (USD Billion)
    8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
      1. 7.9.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.9.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
      3. 7.9.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
      4. 7.9.4 BY END-USE, 2025-2035 (USD Billion)
    9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
      1. 7.10.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.10.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
      3. 7.10.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
      4. 7.10.4 BY END-USE, 2025-2035 (USD Billion)
    10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
      1. 7.11.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.11.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
      3. 7.11.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
      4. 7.11.4 BY END-USE, 2025-2035 (USD Billion)
    11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.12.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.12.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
      3. 7.12.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
      4. 7.12.4 BY END-USE, 2025-2035 (USD Billion)
    12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.13.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.13.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
      3. 7.13.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
      4. 7.13.4 BY END-USE, 2025-2035 (USD Billion)
    13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
      1. 7.14.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.14.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
      3. 7.14.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
      4. 7.14.4 BY END-USE, 2025-2035 (USD Billion)
    14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
      1. 7.15.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.15.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
      3. 7.15.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
      4. 7.15.4 BY END-USE, 2025-2035 (USD Billion)
    15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
      1. 7.16.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.16.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
      3. 7.16.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
      4. 7.16.4 BY END-USE, 2025-2035 (USD Billion)
    16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
      1. 7.17.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.17.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
      3. 7.17.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
      4. 7.17.4 BY END-USE, 2025-2035 (USD Billion)
    17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
      1. 7.18.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.18.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
      3. 7.18.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
      4. 7.18.4 BY END-USE, 2025-2035 (USD Billion)
    18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
      1. 7.19.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.19.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
      3. 7.19.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
      4. 7.19.4 BY END-USE, 2025-2035 (USD Billion)
    19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
      1. 7.20.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.20.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
      3. 7.20.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
      4. 7.20.4 BY END-USE, 2025-2035 (USD Billion)
    20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.21.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.21.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
      3. 7.21.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
      4. 7.21.4 BY END-USE, 2025-2035 (USD Billion)
    21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.22.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.22.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
      3. 7.22.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
      4. 7.22.4 BY END-USE, 2025-2035 (USD Billion)
    22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
      1. 7.23.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.23.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
      3. 7.23.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
      4. 7.23.4 BY END-USE, 2025-2035 (USD Billion)
    23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
      1. 7.24.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.24.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
      3. 7.24.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
      4. 7.24.4 BY END-USE, 2025-2035 (USD Billion)
    24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
      1. 7.25.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.25.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
      3. 7.25.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
      4. 7.25.4 BY END-USE, 2025-2035 (USD Billion)
    25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.26.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.26.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
      3. 7.26.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
      4. 7.26.4 BY END-USE, 2025-2035 (USD Billion)
    26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.27.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.27.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
      3. 7.27.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
      4. 7.27.4 BY END-USE, 2025-2035 (USD Billion)
    27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
      1. 7.28.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.28.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
      3. 7.28.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
      4. 7.28.4 BY END-USE, 2025-2035 (USD Billion)
    28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
      1. 7.29.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.29.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
      3. 7.29.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
      4. 7.29.4 BY END-USE, 2025-2035 (USD Billion)
    29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.30.1 BY SERVICE, 2025-2035 (USD Billion)
      2. 7.30.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
      3. 7.30.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
      4. 7.30.4 BY END-USE, 2025-2035 (USD Billion)
    30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.31.1
    1. 7.32 ACQUISITION/PARTNERSHIP
  10. 7.32.1

Medical Device Design Development Services Market Segmentation

Medical Device Design Development Services Market By Service (USD Billion, 2025-2035)

  • Designing & Engineering
  • Machining
  • Molding
  • Packaging

Medical Device Design Development Services Market By Medical Device Design Development Services Markets (USD Billion, 2025-2035)

  • Cardiovascular Devices
  • POC Diagnostic Equipment
  • Hb1Ac Testing
  • Drug Delivery Devices
  • Orthopedic Devices
  • Dental Devices
  • Surgical Devices
  • Imaging Devices
  • Sleep & Respiratory Devices
  • Ophthalmology Devices
  • Endoscopy
  • Diabetes Care
  • Cochlear Implants
  • Neurostimulators
  • Others

Medical Device Design Development Services Market By Therapeutic Area (USD Billion, 2025-2035)

  • Cardiovascular
  • Diagnostic
  • Others

Medical Device Design Development Services Market By End-Use (USD Billion, 2025-2035)

  • Medical Device Design Development Services Market Companies
  • Biotechnology Companies

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.